• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Forbion-backed biotech Progentos debuts with $65M for MS drug

cafead

Administrator
Staff member
  • cafead   May 20, 2024 at 06:12: PM
via Progentos says the money will go toward expanding its pipeline and pushing an experimental treatment for multiple sclerosis through “proof of concept” testing.

article source